Riboxin pills p/o 200mg №10×5

Name:
Riboxin tabl.p/o 200mg in cell.pack No. 10×5
Description:
Coated tablets, from light yellow to yellow with an orange tint, with a biconvex surface. On the surface of the tablets, the roughness of the film coating is allowed. The main active ingredient Inosine Release form Tablets Dosage 200 mg Pharmacological action Inosine is an anabolic substance. It exhibits antihypoxic and antiarrhythmic properties, has an anabolic effect. Inosine has a positive effect on the metabolism in the myocardium, increases the energy balance of cells, increases the strength of heart contractions and contributes to a more complete relaxation of the myocardium in diastole. As a result, the stroke volume of the heart increases. The drug also reduces platelet aggregation, activates tissue regeneration. Indications for use In the complex therapy of coronary heart disease, after myocardial infarction, cardiac arrhythmias caused by the use of cardiac glycosides. In the complex therapy of liver diseases (hepatitis, cirrhosis, fatty degeneration of the liver caused by alcohol or drugs) and urocoproporphyria. Dosing and Administration The daily dose for oral administration is 600-2400 mg. In the first days of treatment, the daily dose is 600-800 mg (200 mg 3-4 times a day). In case of good tolerance, the daily dose is increased (for 2-3 days) to 1200 mg, if necessary, up to 2400 mg / day. The course of treatment – from 4 weeks to 1.5-3 months. With urocoproporphyria, the daily dose is 800 mg (1 tablet 4 times a day), the duration of the course of treatment is 1-3 months. If you forget to take a medicine, do not double the dose to make up for the missed one. Do not stop taking Riboxin without first consulting with your doctor. Use during pregnancy and lactation If you are pregnant or breastfeeding, if you think you are pregnant or do not rule out the possibility of pregnancy, tell your doctor. Due to insufficient data on the safety of the drug during pregnancy and lactation, Riboxin is prescribed taking into account the benefit / risk ratio. Influence on the ability to drive a car and potentially dangerous mechanisms The drug does not affect the ability to drive vehicles and other potentially dangerous mechanisms. Precautions Riboxin is not used for emergency correction of cardiac disorders. With prolonged use of the drug, the concentration of uric acid in the blood serum and urine should be monitored. In renal failure, the use of the drug is possible only if the expected positive effect outweighs the potential risk. With the appearance of itching and hyperemia of the skin, the use of the drug should be discontinued. The drug contains sugar, which should be taken into account in patients with diabetes mellitus. Children. There are no studies on the use of the drug in children. The drug should not be used in childhood. Interaction with other drugs If you are currently or have recently taken other drugs, tell your doctor. No negative manifestations of drug interactions of Riboxin with other drugs for the treatment of diseases of the cardiovascular system have been reported. When combined with cardiac glycosides, the drug can prevent the occurrence of arrhythmias and enhance the inotropic effect. Enhances the effect of heparin and increases the duration of its action. Combined use with hypouremic agents weakens their effect. When taken with beta-blockers, the effect of Riboxin does not decrease. Perhaps simultaneous use with nitroglycerin, nifedipine, furosemide, spironolactone. With simultaneous use enhances the effects of anabolic steroids and non-steroidal anabolic agents. Weakens the bronchodilator effect of theophylline and the psychostimulant effect of caffeine. Incompatible with alkaloids, when interacting with them, the alkaloid base is separated and insoluble compounds are formed. Incompatible with acids and alcohols, salts of heavy metals. Incompatible with vitamin B6 (pyridoxine hydrochloride) as deactivation of both compounds occurs. ContraindicationsIncreased individual sensitivity to the active substance or any other component of the drug, gout, hyperuricemia, children under 18 years of age. Carefully. Renal failure. Composition Each tablet contains the active substance: riboxin (inosine) – 200 mg; excipients: methylcellulose, calcium stearate, sugar, potato starch, opadra II yellow. shell composition (Opadry II yellow): polyvinyl alcohol, titanium dioxide, talc, polyethylene glycol, iron (III) oxide yellow, coloring pigment – aluminum varnish based on quinoline yellow E104. OverdoseSymptoms: increased side effects (urticaria, pruritus, increased levels of uric acid in the blood, exacerbation of gout). Treatment: symptomatic therapy. There is no specific antidote. Side effects When using the drug, the following adverse reactions may occur: From the side of the cardiovascular system: tachycardia; arterial hypotension, which may be accompanied by headache, shortness of breath, dizziness, nausea, vomiting, sweating. From the immune system: allergic / anaphylactic reactions, including rashes, itching, skin flushing, urticaria, anaphylactic shock. From the side of metabolism, metabolism: hyperuricemia, exacerbation of gout (with prolonged use of high doses). Others: general weakness, increased levels of uric acid in the blood. If side effects occur, tell your doctor about it. This applies to all possible side effects, including those not described in this package insert. Storage conditions Store in a place protected from moisture and light at a temperature not exceeding 25°C. Keep out of the reach of children. Buy Riboxin tablets p/o 200mg №10×5 Price for Riboxin tablets p/o 200mg №10×5